Trial intelligence / Profile preview

GSK1562902A Pandemic Influenza Vaccine Consistency in Adults

NCT00449670Phase 3Completed

Sponsor
GSK
Start
Mar 2007
Primary completion
Jul 2007
Countries
4
01

Overview

A Phase 3 trial of Adjupanrix in influenza, sponsored by GSK. Started Mar 2007; status: completed.

02

Drugs

Adjupanrix
03

Conditions

influenza

Beyond the preview

Go deeper on NCT00449670.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00449670.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call